Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - OTHER LIABILITIES
Other Liabilities EXEL - Exelixis, Inc.
109 M
LAST VALUE
32.58%
2 YEAR CAGR
115.43%
5 YEAR CAGR
29.00%
10 YEAR CAGR